Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 976 AL 990

Transcriptional signatures of brain aging and Alzheimer's disease: What are our rodent models telling us?

Hargis KE, Blalock EM.

Behav Brain Res. 2017 Mar 30;322(Pt B):311-328. doi: 10.1016/j.bbr.2016.05.007. Epub 2016 May 4.

Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease

Pugazhenthi S, Qin L, Reddy PH.

Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1037-1045. doi: 10.1016/j.bbadis.2016.04.017. Epub 2016 May 6.

Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer's disease

Foster TC, Kyritsopoulos C, Kumar A.

Behav Brain Res. 2017 Mar 30;322(Pt B):223-232. doi: 10.1016/j.bbr.2016.05.012. Epub 2016 May 11.

Analysis of recent failures of disease modifying therapies in Alzheimer's disease suggesting a new methodology for future studies

Amanatkar HR, Papagiannopoulos B, Grossberg GT.

Expert Rev Neurother. 2017 Jan;17(1):7-16. doi: 10.1080/14737175.2016.1194203. Epub 2016 Jun 9.

Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain

Abolhassani N, Leon J, Sheng Z, Oka S, Hamasaki H, Iwaki T, Nakabeppu Y.

Mech Ageing Dev. 2017 Jan;161(Pt A):95-104. doi: 10.1016/j.mad.2016.05.005. Epub 2016 May 24.

Autophagy and Alzheimer's Disease

Li Q, Liu Y, Sun M.

Cell Mol Neurobiol. 2017 Apr;37(3):377-388. doi: 10.1007/s10571-016-0386-8. Epub 2016 Jun 3.

A novel CCM2 variant in a family with non-progressive cognitive complaints and cerebral microbleeds

Cohn-Hokke PE, Holstege H, Weiss MM, van der Flier WM, Barkhof F, Sistermans EA, Pijnenburg YA, van Swieten JC, Meijers-Heijboer H, Scheltens P.

Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):220-226. doi: 10.1002/ajmg.b.32468. Epub 2016 Jun 8.

Oxidative stress, protein modification and Alzheimer disease

Tramutola A, Lanzillotta C, Perluigi M, Butterfield DA.

Brain Res Bull. 2017 Jul;133:88-96. doi: 10.1016/j.brainresbull.2016.06.005. Epub 2016 Jun 15.

Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models

Spangenberg EE, Green KN.

Brain Behav Immun. 2017 Mar;61:1-11. doi: 10.1016/j.bbi.2016.07.003. Epub 2016 Jul 6.

The blood-brain barrier in Alzheimer's disease

Zenaro E, Piacentino G, Constantin G.

Neurobiol Dis. 2017 Nov;107:41-56. doi: 10.1016/j.nbd.2016.07.007. Epub 2016 Jul 15.

Involvement of Luteinizing Hormone in Alzheimer Disease Development in Elderly Women

Rao CV.

Reprod Sci. 2017 Mar;24(3):355-368. doi: 10.1177/1933719116658705. Epub 2016 Jul 20.

Association between naturally occurring antiamyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease

Menendez-Gonzalez M.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):96-97. doi: 10.1136/jnnp-2016-314136. Epub 2016 Aug 2.

Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease

Habib A, Sawmiller D, Tan J.

J Neurosci Res. 2017 Apr;95(4):973-991. doi: 10.1002/jnr.23823. Epub 2016 Aug 17.

Astroglial calcium signalling in Alzheimer's disease

Verkhratsky A, Rodríguez-Arellano JJ, Parpura V, Zorec R.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1005-1012. doi: 10.1016/j.bbrc.2016.08.088. Epub 2016 Aug 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias